Sun Pharma
Signals mentioning Sun Pharma
- Hospitals seek differentiated pricing rules after Maharashtra FDA flags steep consumable markups
- RBI moves to safeguard its position in Tata Sons listing dispute
- India’s GLP-1 drug market could reach Rs 15,700 crore by FY32, led by generics
- Adani Airports to raise $1B for expansion, Airport City and non-aeronautical growth
- IPC to set uniform semaglutide quality standards as Indian generic market expands
- Sun Pharma’s 11 eye-drop withdrawal exposes recall disclosure gaps
- Fleetx.ai acquires Pando.ai to build AI-native fleet-to-freight platform
- Delhi HC requires Sun Pharma to seek clearance before semaglutide launch
- Sun Pharma withdraws 11 eye-drug brands in India after contamination concerns
- Sun Pharma recalls 11 eye-care products after bacterial contamination concerns
- NPPA caps retail prices for 23 new drug formulations in India
- Sun Pharma recalls 10 eye-drop brands over possible contamination
- Sun Pharma recalls 10 eye-drop brands over contamination concerns
- Sun Pharma recalls select eye drops in India after contamination concern
- Sun Pharma halts distribution and recalls multiple eye-drop products as a precaution
- Sun Pharma Q1FY27 profit rises 27% as India formulations grow 16%
- HDFC Securities sees FY27 consumer recovery, but input volatility clouds margins
- India pharma market grows 16% as drugmakers enter US tariff-free transition
- GTRI flags proposed US generic-drug tariffs as major risk for Indian pharma exporters
- Indian generic drugmakers face potential US tariff shock from 2028